loader

nasdaq:alvr

LATEST ARTICLES
Kalaris Appoints Laurie Keating to Board of Directors

Kalaris Appoints Laurie Keating to Board of Directors

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement

Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement

Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD

Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD

Kalaris to Present at Stifel 2025 Annual Healthcare Conference

Kalaris to Present at Stifel 2025 Annual Healthcare Conference

AlloVir Inc.

AlloVir Inc.

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES